Protracted bacterial bronchitis (PBB) is a treatable cause of chronic wet cough in children but is frequently missed.Unrecognized children often cycle through repeat asthma treatment, short antibiotic courses that do not address the infection, or open-ended reassurance without further evaluation.This review summarizes the clinical presentation, diagnostic criteria, differential diagnosis, treatment, and follow-up of PBB in children.We conducted a targeted narrative review (PubMed, through September 2026) of clinical trials, longitudinal studies, systematic reviews, and professional-society guidance, distinguishing evidence for antibiotic treatment from limited observational evidence linking recurrent PBB to bronchiectasis.Clinicians should suspect PBB in a child with a daily wet cough lasting more than four weeks and no findings indicating another cause.Resolution after an appropriate antibiotic course supports the diagnosis.Amoxicillinclavulanate remains the usual first-line treatment, typically for two weeks initially, with reassessment and selective extension to four weeks if the child has not cleared.Further investigation is warranted when symptoms persist despite adequate treatment, recurrence is frequent, or specific warning signs appear.In an otherwise typical, treatment-responsive case, bronchoscopy and chest computed tomography (CT) are not routine first steps.Management hinges on recognizing the wet-cough phenotype, giving an adequate therapeutic trial, confirming resolution, and investigating promptly when treatment fails.Antibiotics appear to improve cough resolution, but this rests on a small number of trials with limited certainty, and evidence that treatment itself prevents bronchiectasis remains thin.
Background: Emergency discharge is an established option for selected adults with uncomplicated acute diverticulitis. Treatment failure is difficult to predict accurately. This focused review examined baseline clinical, laboratory, and computed tomography predictors alongside outpatient outcomes. Methods: Original studies published through 31 May 2026 were examined for computed tomography confirmation, outpatient management, and subsequent deterioration. Ten outpatient studies were summarized descriptively. Broader prognostic cohorts were considered separately because their populations and outcomes differed from immediate emergency discharge. Results: Selected outpatient cohorts recorded low admission rates, including 2/70, 3/66, 4/155, and 4/140 patients in four studies. A randomized outpatient trial recorded hospitalization in 8/242 participants without antibiotics and 14/238 receiving antibiotics. Persistent pain and oral intolerance accounted for several treatment escalations. Imaging associations were imprecise and differed between studies. Different outcome definitions and follow-up periods restricted comparisons of failure frequencies across treatment protocols. Broader cohorts identified free fluid, female sex, elevated C-reactive protein, systemic comorbidity, vomiting, and prolonged symptoms as prognostic signals. Conclusions: Outpatient outcomes were better after structured selection and follow-up. Inflammatory burden, imaging abnormalities, and symptom persistence warrant particular attention. The data supports individualized assessment rather than a universal discharge score, with explicit separation of readmission, complicated progression, and recurrent episodes when interpreting treatment failure across different clinical settings.
acute diverticulitisuncomplicated diverticulitistreatment failurepredictors of treatment failure
American Journal of Pediatrics · مجلد 12 (3) · 87-102
Background: Parapneumonic effusion (PPE) and empyema remain serious complications of childhood pneumonia associated with significant morbidity despite advances in antimicrobial therapy and surgical techniques. Accurate disease staging and timely stage-directed intervention are fundamental to optimal outcomes. Objective: To provide a current, evidence-based synthesis of the definition, etiology, diagnosis, and management of complicated pneumonia in children, with particular focus on areas of ongoing clinical controversy. Methods: A narrative review incorporating randomized controlled trials, systematic reviews, meta-analyses, Cochrane reviews, and international clinical guidelines published between 2016 and 2026 was conducted. PubMed was searched through May 2026 using terms including pneumonia, complicated pneumonia, parapneumonic effusion, empyema, VATS, fibrinolysis, decortication, and pediatric. Results: Chest radiography remains the initial imaging modality for suspected complicated pneumonia, with lateral decubitus views needed to assess pleural fluid mobility. However, chest ultrasonography is the preferred imaging modality for evaluating parapneumonic effusions and empyema because of its superior diagnostic accuracy, ability to characterize pleural collections, and absence of ionizing radiation. Management is stage-dependent, combining targeted antibiotic therapy with procedural intervention when indicated. Image-guided pigtail catheter drainage with intrapleural fibrinolytic therapy is effective for most patients. VATS demonstrates particular utility during the fibrinopurulent stage. No single fibrinolytic agent has demonstrated clear superiority; however, tissue plasminogen activator is most widely employed. Open decortication remains reserved for refractory or advanced-stage disease. Conclusion: Early diagnosis, appropriate antibiotics, and prompt intervention or surgery are all important for optimal care. The optimal outcomes require a multidisciplinary, individualized, stage-directed approach. Interventional radiology is appropriate for single loculations, while early VATS is favored for thick pleural rind or multiple loculations. Further high-quality prospective research is needed to establish definitive treatment algorithms.
BACKGROUND: Congenital bronchoesophageal fistula (BEF) is a rare communicating bronchopulmonary foregut malformation (CBPFM) characterized by an abnormal connection between the esophagus and a bronchial segment or lung tissue. While esophageal atresia (EA), with or without tracheoesophageal fistula, occurs in approximately 2-3 per 10,000 live births, EA associated with CBPFM/congenital BEF is far rarer, with no established population-based incidence and only several dozen reported CBPFM cases in the literature. Most congenital BEFs present in childhood or adulthood with chronic, nonspecific respiratory symptoms and recurrent infections, whereas neonatal presentations are typically linked to major associated anomalies such as EA. Importantly, complex neonatal constellations-particularly those combining EA with bronchial atresia and a severely hypoplastic, non-aerated lung-may represent an atypical CBPFM variant that does not fit neatly within traditional BEF classification schemes. CASE PRESENTATION: We report a premature Arab female infant born at 32 weeks gestation who presented with respiratory distress, copious oral secretions, and radiographic features of EA with complete right hemithorax opacification and mediastinal shift to the right on a chest X-ray (CXR). After initial stabilization, a gastrostomy tube was inserted. Contrast studies via the gastrostomy tube and computed tomography angiography (CTA) revealed EA with a fistulous communication between the distal esophagus and right bronchial structures, along with a severely hypoplastic right lung. On day 33 of life, the patient underwent surgery. Intraoperative findings confirmed a fistula between the atretic right main bronchus and the lower esophagus, with a nonfunctioning right lung. Definitive EA repair and right pneumonectomy were performed. Histopathology revealed bronchial atresia involving the right main bronchus with right pulmonary hypoplasia. The postoperative course was complicated by pneumothorax, pneumomediastinum, sepsis, and persistent anastomotic leakage, and was managed conservatively with drainage, antimicrobial/antifungal therapy, and prolonged total parenteral nutrition. Serial contrast studies confirmed gradual leak resolution, and oral feeding was started by postoperative day 87. On follow-up, the infant initially maintained oxygen saturation and stable vital signs in room air without respiratory support; however, feeding advancement was complicated by recurrent vomiting and suspected delayed gastric emptying/gastroparesis. Despite combined parenteral and enteral nutrition and a trial of continuous orogastric tube feeding, the infant later developed severe septic shock requiring intravenous antibiotics and ventilatory support. The septic shock was refractory, and the patient died at 5 months of chronological age, corresponding to approximately 3 months corrected age. CONCLUSION: This case represents an atypical congenital BEF variant in which EA coexists with a distal esophageal fistula to an atretic right main bronchus and a severely hypoplastic, non-aerated right lung, highlighting a classification-challenging phenotype. It underscores the crucial role of early targeted imaging in neonates with suspected EA and unilateral lung hypoplasia/atresia. Advanced imaging enables accurate diagnosis and guides surgical planning, while the fatal follow-up course highlights the clinical vulnerability of these patients and the need for careful long-term multidisciplinary monitoring.
BACKGROUND: Gastrointestinal Panel (GIP), allow rapid and comprehensive detection of enteric pathogens; however, evidence on their utility from Saudi Arabia is lacking. This study therefore aimed to assess the prevalence of enteric pathogens, determine the detection yield of the FilmArray GIP, and explore its potential impact on clinical management. METHODS: We conducted a retrospective cohort study at Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia, from January 2023 to December 2024. All adult patients (≥ 18 years) with suspected AGE tested using the FilmArray GIP were eligible for inclusion. Clinical and laboratory data, GIP findings, antimicrobial therapy, and clinical outcomes were extracted from electronic medical records. RESULTS: A total of 176 adult patients with AGE were included in this analysis. The FilmArray GIP detected bacterial pathogens in 86.4% of patients, while viral and parasitic agents were identified in 20.5% and 10.2% of the cohort, respectively. Co-detections were observed in 46.6% of patients, although their clinical relevance remains uncertain. Stool microscopy failed to detect any parasitic pathogens, whereas the multiplex panel identified parasites in 18 patients (p < 0.001). Detection of Salmonella was more than five times higher with the FilmArray GIP compared with stool culture (18.2% versus 3.4%; p < 0.001). The FilmArray GIP was associated with antimicrobial modifications, with no antibiotics prescribed in 30.1% of patients, whereas targeted antimicrobials were initiated in 27.3%. Notably, 8.5% of cases required transmission-based isolation, with Clostridioides difficile infections were more frequently associated with isolation compared with norovirus cases (42.3% versus 15.4%; p = 0.11). CONCLUSIONS: The FilmArray GIP demonstrated higher detection yield for enteric pathogens compared with conventional diagnostic techniques. Rapid identification of enteric pathogens was temporally associated with antimicrobial optimization and infection control decisions. Taken together, these findings highlight the potential role of syndromic molecular testing in the management of adult AGE. CLINICAL TRIAL NUMBER: Not applicable.
One of the most prevalent human infections is Helicobacter pylori (H. pylori), which affects more than half of the global population. Although H. pylori infections are widespread, only a minority of individuals develop severe gastroduodenal disorders. The global resistance of H. pylori to antibiotics has reached concerning levels, significantly impacting the effectiveness of treatment. Consequently, the development of vaccines targeting virulence factors may present a viable alternative for the treatment and prevention of H. pylori infections. This review aims to provide a comprehensive overview of the current understanding of H. pylori infection, with a particular focus on its virulence factors, pathophysiology, and vaccination strategies. This review discusses various virulence factors associated with H. pylori, such as cytotoxin-associated gene A (cagA), vacuolating cytotoxin gene (vacA), outer membrane proteins (OMPs), neutrophil-activated protein (NAP), urease (ure), and catalase. The development of vaccines based on these virulence characteristics is essential for controlling infection and ensuring long-lasting protection. Various vaccination strategies and formulations have been tested in animal models; however, their effectiveness and reproducibility in humans remain uncertain. Different types of vaccines, including vector-based vaccines, inactivated whole cells, genetically modified protein-based subunits, and multiepitope nucleic acid (DNA) vaccines, have been explored. While some vaccines have demonstrated promising results in murine models, only a limited number have been successfully tested in humans. This article provides a thorough evaluation of recent research on H. pylori virulence genes and vaccination methods, offering valuable insights for future strategies to address this global health challenge.
Bacterial biofilms pose a substantial challenge in healthcare and industrial and environmental settings because of their resilience and antibiotic resistance. Biofilm formation is a complex process involving microbial communities encased in an extracellular matrix that contributes to increased resistance and persistent infections. This review explores the emerging roles of bacteriophages and their derived enzymes as promising alternatives or adjunct therapies to combat bacterial biofilms. Bacteriophages, viruses that infect bacteria, exhibit marked specificity and diverse mechanisms for targeting and lysing bacterial cells within biofilms. Enzymes, including endolysins and depolymerases, have demonstrated efficacy in disrupting biofilm matrices. Moreover, the potential synergy between bacteriophages and antibiotics enhances their antimicrobial activity, providing a multifaceted approach for combating biofilm-associated infections. This review critically evaluates the current research, highlighting the successes and limitations of bacteriophage-based strategies in biofilm control, and underscores the potential of these alternatives in shaping future therapeutic interventions against biofilm-related bacterial infections.
Journal of Cellular and Molecular Medicine · مجلد 29 (6) · e70487-e70487
Effective therapy against Helicobacter pylori hinges on a timely and accurate diagnosis. The objective is to assess H. pylori infection in dyspeptic patients and compare various indicative tests. After approval, gastrointestinal biopsies and blood samples of 96 subjects exhibiting gastroduodenal symptoms were collected; both invasive and non-invasive tests were employed to analyse the samples. Results revealed 40 cases (41.67%) positive for H. pylori via histopathology and rapid urease testing, while 46 subjects tested positive for IgA and IgG antibodies via ELISA. Eighteen biopsies showed positivity in the culture test, corroborated by endoscopic examination and biochemical assessments (urease, catalase and oxidase). The isolates showed various degrees of resistance to antibiotics, while polymyxin B showed the highest (100%) followed by amoxicillin (88.90%) and kanamycin (77.78%). Additionally, the CagA gene presence was detected in 18 individuals through molecular methods. Sensitivity and specificity percentages (%) varied among diagnostic methods: histopathology (95/77), rapid urease (100/83.5), gram staining (85.7/90), IgG serology (100/66.6), IgA serology (100/79.5), PCR (100/75), RUT and IgG serology combination (100/79.04), and RUT, Gram staining and IgG serology combination (100/92.4), respectively. PCR emerged as the most reliable test. In the current investigation, other tests also exhibited high sensitivity and specificity values. Thus, employing comparative detection methods rather than relying solely on one methodology is advisable for accurate detection.
Helicobacter pylori infectiondiagnostic test comparisonrapid urease testserological diagnosis
International Journal of Environmental Research and Public Health · مجلد 22 (6) · 868-868
BACKGROUND: Antibiotic resistance (AR) is a global public health crisis, largely driven by the misuse and overuse of antibiotics. This study aimed to assess the level of knowledge, attitude, and practice (KAP) toward AR among non-medical university students in Riyadh, Saudi Arabia and identify factors that influence antibiotic use. METHODS: A cross-sectional survey was conducted with 672 students from both public and private universities in Riyadh. Data were collected using a self-administered questionnaire covering sociodemographic characteristics and KAP regarding antibiotics. RESULTS: The findings indicated that 59.1% of students had sufficient knowledge of antibiotics, while 60% had positive attitudes, and 60.6% exhibited responsible practices. However, 40.9% of students demonstrated insufficient knowledge, and factors such as age, gender, and field of study significantly impacted KAP outcomes. Females had 65.8% higher odds of demonstrating a positive attitude toward AR prevention, compared to males, and 52% higher odds of adopting appropriate practices than males. The primary source of information on antibiotics was healthcare professionals, particularly doctors. CONCLUSIONS: These findings underscore the need for targeted educational interventions to enhance awareness and promote the responsible use of antibiotics among university students, helping to mitigate the threat of antibiotic resistance.
antibiotic resistanceantibiotic misuseantibiotic overuseknowledge, attitudes and practices
Sepsis is a life-threatening condition, and early recognition in the emergency department (ED) is crucial for reducing mortality. However, traditional ED sepsis screening tools (e.g., Systemic Inflammatory Response Syndrome (SIRS) and quick Sequential Organ Failure Assessment (qSOFA)) often lack sensitivity for early detection. Machine learning (ML)-based early warning systems have been proposed to address this gap by analyzing complex clinical data in real time. To address this, we systematically reviewed studies (2015-2025) assessing ML-based sepsis warning systems in adult EDs. Databases searched included PubMed, Embase, Scopus, and Web of Science. Included studies reported diagnostic performance and/or clinical outcomes. Overall, a total of 11 studies (primarily retrospective, with a few prospective) were included. ML models using vital signs, laboratory results, and electronic health record (EHR) data demonstrated high discrimination for sepsis, with area under the receiver operating characteristic curve (AUROC) values often exceeding 0.80, and outperformed traditional scoring tools. Many provided earlier warnings, often two to four hours before sepsis was clinically recognized. Implementation studies showed that ML-based alerts expedited treatment; one multi-center system reduced time to antibiotics by ~1.8 hours when alerts were promptly addressed. Some reports noted reduced organ failure and mortality. However, evidence of improved patient outcomes remains inconsistent, likely due to study heterogeneity and limited prospective validation. ML-based early warning systems show strong potential for improving sepsis recognition and treatment in EDs. Further multi-center trials are needed to confirm their impact on outcomes and guide safe implementation.
sepsisearly warning systemsmachine learningemergency department
BACKGROUND: Acinetobacter baumannii is an opportunistic bacteria associated primarily with hospital-acquired infections. Its tendency to acquire or donate resistance genes to neighboring bacteria is a major concern. Tetracyclines have shown promise in treating A. baumannii infections, but tetracycline resistance is growing globally in A. baumannii isolates. OBJECTIVES: The study aimed to study (1) the prevalence of multidrug-resistant (MDR) A. baumannii infections at Suez Canal University Hospitals, (2) the distribution of efflux pump genes AdeA &B, TetA, and TetB, and (3) the effect of efflux pump inhibitor (CCCP) on tetracycline-resistant isolates. METHODS: Clinical samples (457) were collected (blood, urine, sputum, ETA, pus, and pleural fluid), followed by A. baumannii isolation and identification, PCR detection of efflux pump genes, and detection of tetracycline susceptibility and its MIC before and after treatment with the efflux pump inhibitor (CCCP). RESULTS: A total of 31 A. baumannii isolates were recovered (6.78%). The highest rate of isolation was from the ICU (48.3%) from the ET aspirate samples (48.3%). The efflux system AdeA and TetB genes were distributed in 100% of isolates, whereas AdeB was found in 93.5% of isolates and the TetA gene in 87.1% of isolates. All A. baumannii isolates were MDR showing resistance to three or more classes of antibiotics. 45% of the isolates showed a 4-fold reduction of MIC and 12.9% showed a 2-fold reduction in the MIC. CONCLUSIONS: Efflux pump is an important mechanism for tetracycline resistance among A. baumannii isolates.
Zanco Journal of Medical Sciences · مجلد Special (October 2025) · 423-434
Background and objective: Antimicrobial resistance is a crucial health concern around the world, giving rise to millions of deaths each year. Despite the existence of recommendations for antimicrobial stewardship programs (ASP), the problem persists, particularly in conflict-affected areas such as the Middle East. The aim of this study is to investigate pharmacists’ attitude and practices towards ASP in Erbil, Iraq. Methods: A cross-sectional observational study was conducted among community pharmacies in Erbil City, Iraq, from March 2023 to May 2023. 170 Pharmacists completed an electronic questionnaire consisting of three sections: sociodemographic information, perception of ASP, and practices related to ASP. Statistical analysis was performed by using statistical package SPSS version 22 for the social science data. Results: The questionnaire was completed by 170 participants in total, 85 of whom were female and 85 of whom were male. The majority of participants 65.9% were between the ages of 20 and 30, and 71.2% had bachelor's degrees in pharmacy. The survey indicated 28.2% strongly agreed that “AMS programs improve patient care.” Furthermore, 33.5% strongly agreed that “AMS programs help reduce antimicrobial resistance,” and 31.2% said they frequently administer antibiotics based on complete clinical information. While 24.7% occasionally administered antibiotics in accordance with local guidelines, 33.5% occasionally dispensed antibiotics without a prescription. Notably, 47.6% of those surveyed claimed they would never dispense antibiotics for periods longer than prescribed, even upon patient request. Conclusion: The study shows that community pharmacists in Erbil have favorable views and are responding appropriately to promote antimicrobial stewardship. However, there is room for improvement, especially when it comes to promoting inter-professional collaboration, incorporating AMS programs into community pharmacies, and addressing the issue of providing antibiotics without a valid prescription. These results highlight the necessity of continued measures for patient awareness, education, and training in order to improve the prudent use of antibiotics and guarantee patient safety.
Saudi Pharmaceutical Journal · مجلد 33 (5) · 41-41
Antimicrobial resistance (AMR) is rising alarmingly in Saudi Arabia, as evidenced by surveillance data. This retrospective cohort study evaluated the association between parenteral antimicrobial use and bacterial resistance at King Khaled Hospital, Al-Kharj, using electronic health records. Linear regression analyzed antibiotic exposure-resistance relationships over 36 months (January 2022–December 2024). Eligible participants were hospitalized ≥ 48 h and received ≥ 1 parenteral antimicrobial. The required sample size was 384 (calculated via Cochran’s formula). Inclusion mandated laboratory-confirmed bacterial infections (positive cultures with susceptibility testing). Investigated pathogens included Escherichia coli , Klebsiella pneumoniae , Pseudomonas aeruginosa , Acinetobacter baumannii , and Staphylococcus aureus . Among 4,007 participants, 59.02% were female, and 73.07% were Saudis. Findings revealed severe AMR, particularly in Escherichia coli and Klebsiella pneumoniae , with high resistance to multiple antibiotic classes. Acinetobacter baumannii exhibited near-pan-drug resistance (> 90% resistance to most antibiotics). Imipenem use strongly correlated with Escherichia coli resistance (R 2 = 1.000, p-value = 0.009), indicating significant carbapenem-driven selection pressure. Meropenem exposure also closely linked to Klebsiella pneumoniae resistance (R 2 = 0.994, p-value = 0.050). Widespread resistance to β-lactams, fluoroquinolones, and aminoglycosides—combined with near-pan-resistant Acinetobacter baumannii —highlights escalating treatment challenges. Crucially, carbapenem usage (imipenem/meropenem) strongly predicted resistance in Escherichia coli and Klebsiella pneumoniae , reinforcing antimicrobial pressure’s role in resistance development. These results emphasize the urgent need for antimicrobial stewardship at King Khaled Hospital to curb carbapenem overuse and combat resistant infections.
Frontiers in Cellular and Infection Microbiology · مجلد 15 · 1604507-1604507
Introduction Complicated wound infections pose a significant challenge to patient recovery and healthcare systems, particularly due to the emergence of less common but highly resistant multidrug-resistant (MDR) pathogens that undermine the efficacy of conventional antibiotic therapies. This growing threat highlights the urgent need for innovative antimicrobial approaches. Methodology In this study, we synthesized eco-friendly silver nanoparticles (AgNPs) using garlic extract to combat complicated wound infections caused by atypical MDR pathogens. Results Genetic sequencing of 16S rRNA gene, aligned with phenotypic identification methods, confirmed that Escherichia fergusonii (E. fergusonii) as a significant atypical pathogen responsible for complicated wound infections, with a prevalence rate of 24% (12 out of 50 cases). Antimicrobial susceptibility testing revealed that all identified E. fergusonii strains exhibited MDR patterns. Garlic extract, analyzed using GC-MS and UPLC-ESI-MS/MS, identified sulfur-containing bioactive compounds such as allyl methyl trisulfide, dimethyl trisulfide, and allicin, which facilitated the biosynthesis of AgNPs. Stable, spherical AgNPs (15–20 nm) with strong antimicrobial properties were confirmed under optimal conditions (10 mL garlic extract, 40°C, pH 8.0). Their properties were validated using UV-Vis spectroscopy, XRD, and TEM. Antibacterial assays of AgNPs showed mean inhibition zones of 28±0.5 mm and MIC values of 100 µg/mL. TEM analysis revealed that AgNPs compromised bacterial membrane integrity, leading to structural damage, increased permeability, and leakage of intracellular contents. Simultaneously, they induced a concentration-dependent depletion of intracellular glutathione (GSH) in E. fergusonii, suggesting that both membrane disruption and oxidative stress synergistically contribute to bacterial cell lysis and death. A strong synergistic interaction was observed between AgNPs, used at a safe concentration below 50 µM as confirmed by cytotoxicity assays, and antibiotics such as ciprofloxacin, as evidenced by a fractional inhibitory concentration (FIC) index of 0.37. Time-kill assays demonstrated rapid bacterial eradication when AgNPs were combined with antibiotics such as ciprofloxacin. Conclusion These findings underscore the promise of garlic-derived silver nanoparticles (AgNPs) as a fast-acting, eco-friendly option for treating complex wound infections caused by atypical multidrug-resistant (MDR) pathogens.
Abstract Background Clostridioides difficile is frequently implicated in colitis and antibiotics-induced diarrhoea in both community and hospital settings around the world, and there reports of resistance to the antibiotics of choice used in the management of its infections. Yet, there is limited information on the structural dynamics of its toxins TcdA and TcdB that could guide potential therapeutic candidates. Aim We undertook a structural insights study into the glucosyltransferase domain (GTD) of Clostridioides difficile toxin A (TcdA). Methods Structural analyses and molecular dynamics simulation (250 ns) were carried out for the various TcdA glucosyltransferase domain of 5UQL, 3SZA, 4DMW, 7U2P, and 7UBY. Results our findings highlights conserved catalytic residues (e.g., Trp101, Glu514), Mn²⁺ coordination, and substrate-binding motifs. Key residues (Lys428, Glu381) were shown to mediate RhoA engagement, while small-molecule and antibody inhibitors targeted both active and allosteric sites. Molecular dynamics revealed RMSD increases to ~ 3.6 Å across five TcdA structures over 250 ns, indicating intrinsic conformational flexibility. Complexes with RhoA or inhibitors showed altered contact profiles and dynamic behaviour, supporting functional plasticity. Principal component analysis (PCA) revealed that the ternary complex 7U2P exhibited the highest global motion, suggestive of catalytically relevant conformational changes. Contact frequency analysis confirmed stable ligand engagement in active complexes and disruption in inhibitor-bound states. Conclusion These findings underscore the structural adaptability of TcdA’s GTD and reveal potential therapeutic targets through inhibition of conserved residues or conformational states essential for substrate recognition and catalysis.